Dr. Micah Chan is a faculty member of the Division of Nephrology within the Department of Medicine. He is Professor of Medicine (CHS) and Clinical Chief for the last 15 years. He has been named a “Top Doctor” by Madison Magazine multiple years. Dr. Chan is a referee for over 20 publications and is a Fellow of the American College of Physicians. He served as an FDA reviewer for Office of Orphan Products Development (OOPD), a member of the ASDIN Clinical Practice Committee and Curriculum Committee Chair, and Editorial Board Member of the Journal of Vascular Access and an Editor of PLOS One Academic. Dr. Chan is a member of the American Society of Nephrology, National Kidney Foundation, American College of Physicians and the American Society of Diagnostic Interventional Nephrology (ASDIN).
Dr. Chan’s clinical focus is the prevention, evaluation and treatment of chronic kidney disease, with special interest in interventional nephrology procedures such as angioplasty, Peritoneal Dialysis Catheter Placement or Removal, Stent Placement for Dialysis Access, Thrombectomy. He is ASDIN certified in interventional nephrology with special expertise in hemodialysis catheters.
View Dr. Micah Chan's publications on NCBI My Bibliography
Dr. Chan’s research interests involve investigating vascular access outcomes, early referral patterns, and shared decision making for CKD patients. Dr. Chan is currently involved in a broad range of clinical outcomes research and PI in multiple randomized clinical trials in vascular access. He currently is the PI of the INPACT AV Access Post Approval Study. He has published over 60 peer-reviewed manuscripts and book chapters. He has chaired national meetings for the NKF and ASDIN and has over 100 presentations. Dr. Chan is currently involved in a broad range of clinical research in interventional nephrology. With his colleagues, he plans to improve access for peritoneal and hemodialysis patients with novel methods of treatment and prevention.